PEDIATRICS Vol. 89 No. 3 March 1992, pp. 401-406
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, X. L.
Right arrow Articles by Dudman, N. P. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, X. L.
Right arrow Articles by Dudman, N. P. B.

Early Expression of the Apolipoprotein (a) Gene: Relationships Between Infants' and Their Parents' Serum Apolipoprotein (a) Levels

Xing L. Wang MB, PhD1, David E. L. Wilcken MD, FRCP, FRACP1, and Nicholas P. B. Dudman MSc, PhD1

1 From the Department of Cardiovascular Medicine, University of New South Wales, Prince Henry/Prince of Wales Hospitals, Sydney, New South Wales, Australia

The serum concentration of apo(a), the unique apolipoprotein of lipoprotein (a), reflects serum lipoprotein (a) levels. High concentrations are associated with increased cardiovascular risk. Inasmuch as atherogenesis may begin in childhood, the early expression of the apo(a) gene and relationships between serum levels in infants and their parents were explored. Serum apo(a) and lipid profiles were measured in 51 infants when aged 8.5 ± 2 months. They were from among 1032 consecutively born babies in whom apo(a) levels had been measured on day 2 to 5. Levels in 18 infants were in the top 5% of the neonatal apo(a) distribution and in 33 from below the 95th percentile. Parental values were also assessed. Infants' apo(a) levels (n = 51) at the ages of 2 to 5 days and 8.5 ± 2.3 months were highly correlated (r .73, P < .0001) and increased from an initial median value of 48 U/L (range 1 to 462 U/L) to 100 U/L (5 to 969 U/L) at 8.5 months, and they were then not different from parental levels. Measurements at both times were closely correlated with parental levels. Regression coefficients between 8.5-month levels, and the levels of fathers, of mothers, and the average level of both parents were 0.439, 0.521 and 0.93, respectively (P < .0001 for each). It is concluded that the gene for the regulation of apo(a) is fully expressed before the age of 1 year. The apo(a) levels in infants during this time track closely and are predictive of parental values. These results are consistent with apo(a) contributing to that part of coronary risk associated with a positive family history, with implications for both future childhood screening and family-based coronary prevention.

Key Words: apolipoprotein (a) • cholesterol • lipoproteins • infants • parents • cardiovascular disease

Submitted on December 7, 1990
Accepted on April 16, 1991




This article has been cited by other articles:


Home page
 J Child NeurolHome page
M. Castro-Gago, M. I. Novo-Rodriguez, M. O. Blanco-Barca, A. Urisarri-Ruiz de Cortazar, J. Rodriguez-Garcia, S. Rodriguez-Segade, and J. Eiris-Punal
Evolution of Serum Lipids and Lipoprotein (a) Levels in Epileptic Children Treated With Carbamazepine, Valproic Acid, and Phenobarbital
J Child Neurol, January 1, 2006; 21(1): 48 - 53.
[Abstract] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
R. P.S. Middelberg, T. D. Spector, R. Swaminathan, and H. Snieder
Genetic and Environmental Influences on Lipids, Lipoproteins, and Apolipoproteins: Effects of Menopause
Arterioscler. Thromb. Vasc. Biol., July 1, 2002; 22(7): 1142 - 1147.
[Abstract] [Full Text] [PDF]

Home page
 J Child NeurolHome page
F. Mujgan Aynaci, F. Orhan, A. Orem, S. Yildirmis, and Y. Gedik
Effect of Antiepileptic Drugs on Plasma Lipoprotein (a) and Other Lipid Levels in Childhood
J Child Neurol, May 1, 2001; 16(5): 367 - 369.
[Abstract] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
H. Snieder, L. J. P. van Doornen, and D. I. Boomsma
Dissecting the Genetic Architecture of Lipids, Lipoproteins, and Apolipoproteins : Lessons From Twin Studies
Arterioscler. Thromb. Vasc. Biol., December 1, 1999; 19(12): 2826 - 2834.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
K. Thorsen, P. Nordström, R. Lorentzon, and G. H. Dahlén
The Relation between Bone Mineral Density, Insulin-Like Growth Factor I, Lipoprotein (a), Body Composition, and Muscle Strength in Adolescent Males
J. Clin. Endocrinol. Metab., September 1, 1999; 84(9): 3025 - 3029.
[Abstract] [Full Text]

Home page
 PediatricsHome page
U. Nowak-Gottl, O. Debus, M. Findeisen, R. Kassenbohmer, H. G. Koch, H. Pollmann, C. Postler, P. Weber, and H. Vielhaber
Lipoprotein (a): Its Role in Childhood Thromboembolism
Pediatrics, June 1, 1997; 99(6): e11 - e11.
[Abstract] [Full Text] [PDF]